Drug Shortage Report for APO-PERINDOPRIL-INDAPAMIDE

Last updated on 2023-09-22 History
Report ID 184092
Drug Identification Number 02297574
Brand name APO-PERINDOPRIL-INDAPAMIDE
Common or Proper name PERINDOPRIL-INDAPAMIDE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) INDAPAMIDE PERINDOPRIL ERBUMINE
Strength(s) 1.25MG 4MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BLS
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-02-07
Estimated end date 2023-09-22
Actual end date 2023-09-15
Shortage status Resolved
Updated date 2023-09-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v45 2023-09-22 French Compare
v44 2023-09-22 English Compare
v43 2023-09-07 French Compare
v42 2023-09-07 English Compare
v41 2023-09-01 French Compare
v40 2023-09-01 English Compare
v39 2023-08-04 French Compare
v38 2023-08-04 English Compare
v37 2023-07-21 French Compare
v36 2023-07-21 English Compare
v35 2023-07-21 English Compare
v34 2023-07-13 French Compare
v33 2023-07-13 English Compare
v32 2023-07-07 French Compare
v31 2023-07-07 English Compare
v30 2023-06-29 French Compare
v29 2023-06-29 English Compare
v28 2023-06-23 French Compare
v27 2023-06-23 English Compare
v26 2023-06-23 French Compare

Showing 1 to 20 of 45